Cure My Disease

Don't miss your cure!

 Log in / Sign up

New asthma drug shows promise in Mid-Stage trial

NCT ID NCT06496607

Disease control Sponsor: Uniquity One (UNI) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study tests an experimental drug, solrikitug, in 145 adults with asthma who already use daily inhalers. The goal is to see if the drug can safely lower certain immune cells (eosinophils) in the blood and improve asthma control compared to a placebo. It is a Phase 2 trial, meaning researchers are still checking safety and how well it works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

145 people

The number who actually took part.

Started

Jul 2024

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key inclusion criteria: * Participant must be aged 18 to 75 years of age. * Documented diagnosis of asthma at least 12 months prior to Screening. * Participants must be on maintenance asthma medications, for at least 3 months prior to screening: inhaled corticosteroid (ICS) in combination with long-acting beta agonist (LABA), or as part of an approved triple therapy for asthma (ICS/LABA/long-acting muscarinic antagonist \[LAMA\]). * Participant has an ACQ-6 score ≥1.5 at Screening Visit. * Participant has FEV1 of ≥50% to 90%, inclusive, of predicted normal value at Screening Visit 1. * Evidence of asthma as documented by reversibility in FEV1 of ≥12% and ≥200 mL over the pre-salbutamol FEV1 at Screening Visit. Key exclusion criteria: * Female participant who is pregnant or breastfeeding. * Participant is a current smoker, or former smoker with a smoking history of ≥10 pack-years. * Participant has a known hypersensitivity to any component of the formulation of solrikitug, including any of the excipients, or a history of anaphylactic reaction to any therapeutic monoclonal antibody. * Participant has history or evidence of any clinically significant cardiovascular, hematologic, hepatic, immunologic, metabolic, urologic, neurologic, dermatologic, psychiatric, renal and/or other major disease or malignancy, or any other condition (risks factors of pneumonia) that in the opinion of the Investigator might obfuscate the study data. * Participant has an exacerbation of asthma requiring use of OCS or hospitalization in the 6 weeks prior to Screening or during the Screening Period. * Participant has history or evidence of any clinically significant pulmonary condition, other than asthma. * Lower respiratory tract infection within the 6 weeks prior to Screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma

Contacts and locations

Locations

  • A1 Clinical

    Queens Village, New York, 11428, United States

  • Accellacare - Duly

    Winfield, Illinois, 60190, United States

  • Aeroallergy Research Laboratories of Savannah, Inc.

    Savannah, Georgia, 31406, United States

  • Allergy & Asthma Associates of Santa Clara Valley

    San Jose, California, 95117, United States

  • Allergy & Asthma Diagnostic Treatment Center

    Lancaster, Pennsylvania, 17601, United States

  • Allergy & Asthma Medical Group and Research Center

    San Diego, California, 92123, United States

  • Allergy, Asthma & Sinus Center, LLC

    Myrtle Beach, South Carolina, 29588, United States

  • Asheville Clinical Research

    Asheville, North Carolina, 28803, United States

  • Axsendo Clinical Research

    Houston, Texas, 77002, United States

  • Beach Physicians Clinical Research Corp.

    Huntington Beach, California, 92647, United States

  • Biosolutions Clinical Research Center

    La Mesa, California, 91942, United States

  • CPCC - Research, LLC

    East Point, Georgia, 30344, United States

  • Care Access - Mauldin

    Mauldin, South Carolina, 29662, United States

  • Care Access, Tamarac

    Tamarac, Florida, 33321, United States

  • Chesapeake Clinical Research, Inc.

    White Marsh, Maryland, 21162, United States

  • Clinical Research Associates of Central PA

    DuBois, Pennsylvania, 15801, United States

  • Clinical Research of Rock Hill

    Rock Hill, South Carolina, 29732, United States

  • Clinical Site Partners LLC dba-Leesburg

    Leesburg, Florida, 34748, United States

  • Coral Research Clinic Corp.

    Miami, Florida, 33186, United States

  • Dallas Allergy and Asthma Center

    Dallas, Texas, 75231, United States

  • Deerborn Clinic

    Dearborn, Michigan, 48126, United States

  • Downtown LA Research Center

    Los Angeles, California, 90017, United States

  • Gulf Coast Clinical Research

    Houston, Texas, 77070, United States

  • Henderson Trials

    Henderson, Nevada, 89052, United States

  • Henry Ford Health System

    Detroit, Michigan, 48202, United States

  • Hillcrest Medical Research, LLC

    DeLand, Florida, 32720, United States

  • IntraCare Clinical

    Greenville, Texas, 75401, United States

  • IntraCare Health Center

    Dallas, Texas, 75254, United States

  • JY Research Institute

    Cutler Bay, Florida, 33189, United States

  • Javarra Research

    Conroe, Texas, 77384, United States

  • MBR - Charleston

    North Charleston, South Carolina, 29406, United States

  • Mayflower Clinical

    South Dartmouth, Massachusetts, 02747, United States

  • Midwest Clinical Research

    Dayton, Ohio, 45417, United States

  • Montana Medical Research, Inc.

    Missoula, Montana, 59808, United States

  • National Clinical Trials

    Cordele, Georgia, 31015, United States

  • New Phase Research & Development

    Knoxville, Tennessee, 37909, United States

  • Newport Native MD, Inc.

    Newport Beach, California, 92663, United States

  • NexGen Research

    Boise, Idaho, 83706, United States

  • North Bay Clinical Research

    Santa Rosa, California, 95405, United States

  • North Carolina Clinical Research

    Raleigh, North Carolina, 27607, United States

  • Northwest Research Center

    Portland, Oregon, 97202, United States

  • OK Clinical Research

    Edmond, Oklahoma, 73034, United States

  • Ogden Clinical Canyon View

    Tallahassee, Florida, 32308, United States

  • Orso Health

    Long Beach, California, 90808, United States

  • Pharmax Research of South Florida

    Miami, Florida, 33126, United States

  • Phoenix Medical Group

    Peoria, Arizona, 85381, United States

  • Premier Research Center, LLC

    Hendersonville, Tennessee, 37075, United States

  • Pro-Care Research Center, Corp.

    Miami Gardens, Florida, 33014, United States

  • Proactive RGV

    Brownsville, Texas, 78520, United States

  • Prospective Research Innovations Inc.

    Rancho Cucamonga, California, 91730, United States

  • Providere Research

    West Covina, California, 91790, United States

  • Pulmonary Research Institute of SE Michigan

    Farmington Hills, Michigan, 48336, United States

  • Revive Research Institute, Inc.

    Southfield, Michigan, 48075, United States

  • San Jose Clinical Trials

    San Jose, California, 95128, United States

  • Southeastern Research Center

    Winston-Salem, North Carolina, 27103, United States

  • TBC Research

    Tamarac, Florida, 33321, United States

  • TTS Research

    Boerne, Texas, 78006, United States

  • Temple University - Shenoy

    Philadelphia, Pennsylvania, 19140, United States

  • Ten20 Clinical Research, LLC

    Carrollton, Texas, 75010, United States

  • Toledo Institute of Clinical Research Inc.

    Toledo, Ohio, 43617, United States

  • Treasure Valley Medical Research

    Boise, Idaho, 83706, United States

  • US Allergy & Asthma

    Frisco, Texas, 75035, United States

  • Velocity Clinical Research

    Mobile, Alabama, 36608, United States

  • Velocity Clinical Research

    Lafayette, Louisiana, 70508, United States

  • Velocity Clinical Research

    Medford, Oregon, 97504, United States

  • Velocity Clinical Research - Denver

    Englewood, Colorado, 80110, United States

  • Velocity Clinical Research - Hampton

    Hampton, Virginia, 23666, United States

  • Velocity Clinical Research - Sioux City

    Sioux City, Iowa, 51106, United States

  • Warren W. Pleskow, M.D.

    Encinitas, California, 92024, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.